Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT06049966
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2023-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atezolizumab in Large Cell Neuroendocrine Carcinoma
Sponsor:
Oncology Center of Biochemical Education And Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-10
First Submit QC Date:
None
Study First Post Date:
2023-09-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-16
Last Update Post Date:
2023-09-22
Last Update Post Date Type:
ACTUAL